NCT06823375 2026-03-04SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein ThrombosisChinese University of Hong KongPhase 2 Recruiting40 enrolled
NCT05873244 2025-03-21CXD101 in Immunotherapy-related Liver CancerChinese University of Hong KongPhase 2 Recruiting44 enrolled